Laser Eye Color Change Patient Eligibility Criteria

This page explains who may be a suitable candidate for the MyLumineyes® Laser Eye Color Change Procedure and which clinical factors may require treatment to be postponed, modified, or declined. Final eligibility can only be confirmed after a complete ophthalmic examination.

Quick Eligibility Snapshot

  • Potential candidates: adults with healthy eyes, stable ocular findings, and realistic expectations.
  • Requires careful review: glaucoma or ocular hypertension history, previous significant eye surgery or trauma, corneal disease, ocular surface disease, or inflammatory eye history.
  • May not be suitable: uncontrolled glaucoma or unstable IOP, active ocular inflammation, significant corneal pathology, severe ocular surface disease, or inability to complete required follow-up.
  • Important: safety and long-term ocular health take priority over cosmetic goals.

Eligibility is determined individually and cannot be confirmed from photographs alone.


Pre-Assessment Checklist

These points can help you understand whether a clinical evaluation is appropriate. A positive answer to a risk factor does not necessarily determine the final outcome; it means that the factor requires medical review.

Proceed to clinical evaluation if most are true

  • You do not have known glaucoma or uncontrolled eye pressure.
  • You do not have active eye inflammation or frequent unexplained redness or pain.
  • You do not have significant corneal disease such as advanced keratoconus, ectasia, severe scarring, or poor epithelial stability.
  • Your general health and ocular condition are stable enough for planned monitoring.
  • You understand that results develop gradually and individual response varies.
  • You understand that an exact final eye-color shade cannot be guaranteed.

Factors requiring careful clinical review

  • History of glaucoma, ocular hypertension, angle narrowing, or previous IOP spikes.
  • Previous serious eye surgery or significant ocular trauma.
  • Uncontrolled dry eye or severe ocular surface disease.
  • Autoimmune or inflammatory eye history, including previously treated inflammation.
  • Previous keratopigmentation or cosmetic iris procedures.
  • Expectations of an exact shade or an unrealistically rapid result.

How We Confirm Eligibility

Eligibility is not determined from eye color or photographs alone. A structured ophthalmic assessment is required to evaluate ocular health, anatomical suitability, baseline risk factors, and the ability to monitor the eye safely.

Pre-Procedural Ophthalmic Screening Protocol

The clinical screening framework uses routine baseline assessment together with targeted investigations when specific findings or risk factors warrant further evaluation.

Routine Baseline Assessment
Slit-Lamp Biomicroscopy

Assessment of iris stromal characteristics, anterior segment anatomy, corneal clarity, and ocular surface stability.

Routine Baseline Assessment
IOP Assessment

Baseline intraocular pressure assessment and review of glaucoma or ocular-hypertension risk factors.

When Clinically Indicated
Anterior Segment OCT & Gonioscopy

Additional assessment when angle narrowing, iridocorneal abnormalities, or other anterior-segment concerns are suspected.

When Clinically Indicated
Specular Microscopy

Considered when corneal endothelial cell density or endothelial morphology requires additional evaluation.

Clinical Assessment
Anterior Segment & Ocular Surface

Review of corneal status, ocular surface condition, and anatomical factors relevant to treatment planning and monitoring.

Clinical Assessment
Retinal & Optic Nerve Review

Overall ocular health is considered as part of the clinical assessment and treatment decision.

Who May Be a Good Candidate?

  • Adults with healthy eyes and stable baseline findings.
  • Patients with realistic expectations regarding gradual change and individual response.
  • Patients able to follow clinical instructions and attend required follow-up visits.
  • Patients seeking a non-incisional approach while accepting safety-first clinical decision-making.
Important: Candidate suitability is determined after examination. Being within a general candidate category does not guarantee eligibility or a particular treatment plan.

Who Should Not Undergo Laser Eye Color Change?

The following are important reasons treatment may be postponed, modified, or declined. This list is not exhaustive, and final decisions are individualized.

Typical Exclusion or High-Risk Categories

  • Uncontrolled glaucoma, high-risk ocular hypertension, or unstable IOP history.
  • Active uveitis or ocular inflammation, or recurrent unexplained inflammatory episodes.
  • Significant corneal pathology, including advanced keratoconus or ectasia, severe scarring, or poor epithelial stability.
  • Severe ocular surface disease that may compromise healing or reliable monitoring.
  • Unreliable follow-up where planned monitoring cannot be completed.
  • Unrealistic expectations or inability to accept medically necessary limitations.

Special Situations

LASIK / PRK / SMILE

Previous refractive surgery does not automatically exclude evaluation. Corneal status and ocular surface stability must be reviewed carefully. If significant dryness or corneal instability is present, treatment may be delayed or may not be advised.

Contact Lens Use

Contact lenses can affect corneal measurements and ocular surface findings. You may be asked to stop lens wear before evaluation to allow accurate assessment.

High Astigmatism or Refractive Error

Refractive error alone does not automatically exclude eligibility. The decision depends on overall ocular health, safety parameters, and monitoring considerations.

Previous Keratopigmentation or Iris Procedures

Previous cosmetic or therapeutic procedures involving the cornea or iris require individual clinical review. Please disclose all previous eye procedures during your evaluation.


Realistic Expectations

  • Results are not instant and develop gradually.
  • Individual response varies.
  • An exact final shade is not guaranteed.
  • Safety parameters take priority over a preferred cosmetic outcome.
  • Clinical monitoring is part of the treatment process.

Alternatives and Safety Warnings

Other eye-color procedures, including intraocular cosmetic implants and corneal tattooing procedures, may involve significant risks. Patients considering eye-color procedures should review established ophthalmic safety information.

Safety-first principle: Patient selection, ophthalmic screening, appropriate monitoring, and individualized clinical decision-making are central to the MyLumineyes® approach.

Frequently Asked Questions

Can you confirm eligibility from photographs?

No. Photographs can be useful for an initial discussion, but eligibility requires a complete ophthalmic examination and clinical risk assessment.

If I have dry eye, am I automatically excluded?

Not necessarily. The significance of dry eye depends on its severity and the condition of the ocular surface. Significant or uncontrolled ocular surface disease may require treatment or stabilization before an eligibility decision is made.

Does previous LASIK, PRK, or SMILE automatically exclude me?

No. Previous refractive surgery does not automatically exclude evaluation. Corneal status and ocular surface stability must be assessed individually.

What if I have glaucoma or high eye pressure?

A history of glaucoma, ocular hypertension, angle narrowing, or previous IOP elevation requires careful clinical assessment. Uncontrolled or unstable conditions may make treatment unsuitable.

Is there a guaranteed final eye color?

No. The final appearance depends on individual ocular characteristics and treatment response. An exact shade cannot be guaranteed.

What examinations are performed before treatment?

Baseline assessment may include slit-lamp biomicroscopy and intraocular pressure assessment. Additional investigations such as anterior segment OCT, gonioscopy, or specular microscopy may be used when clinically indicated.

What if I previously had keratopigmentation or an iris implant?

These situations require individual medical review. Please disclose any previous corneal, iris, or intraocular procedures during your evaluation.

Do I need to attend follow-up visits?

Yes. The ability to complete planned clinical monitoring is an important part of determining whether treatment is appropriate.


Next Step

If you may be a candidate, the next step is a structured clinical evaluation. If you want to understand the procedure first, begin with the official procedure overview.

Medical disclaimer: This page is for educational purposes and does not replace an in-person examination. Treatment decisions are made individually after clinical assessment.

eye color change patient eligibility
Dr. Mustafa Mete - Inventor of MyLumineyes Laser Eye Color Change

Medical Review & Fact-Checking

All medical content is reviewed by Dr. Mustafa Mete, an ophthalmic surgeon with 25 years of clinical experience and 3,000+ laser eye color change cases.

Dr. Mete is the original developer of the patent-pending Lumineyes™ technique, with more than 15 years of clinical experience and over a decade of long-term patient follow-up.

✓ Original Developer
✓ 15+ Years of Clinical Experience
✓ Long-Term Follow-Up
Lumineyes Lumineyes Assistant ×
Structured clinical guidance • No automated free-text answers
Start Here
Ask a question or choose a topic above.
Explore laser iris depigmentation, clinical safety protocols, surgical differences, and long-term permanence.